Skip to main content
Equibles
KYNB $5.21 -1.33%
KYNB logo
KYNB · Kyntra Bio, Inc.
Track KYNB — free

Use KYNB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KYNB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.21 -0.07 (-1.33%)
Rebalance outlook locked
Market Cap
$21.38M
Shares
4.05M
Volume · Oct 21 11.8K Avg daily vol (3M) 19.68K
All webcasts

Earnings call · FY2023 Q1

Kyntra Bio, Inc. (KYNB) Q1 2023 Earnings Call

Concluded May 8, 2023
May 8, 2023 0 turns
Period
FY2023 Q1
Runtime
—
Sources
2 artifacts
Revenue $36.16M -40.6% YoY
Diluted EPS -$20.25
Net income -$76.70M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 8, 2023 10-Q report Filed May 8, 2023

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$24.16M +28% YoY
License$6.00M -73.4% YoY
Development and Other Revenue$3.89M -66.9% YoY
Drug Product Revenue$2.11M -72.2% YoY
Full-screen source Call document

KYNB alerts

Kyntra Bio, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →